Literature DB >> 2068381

Improved purification of leukocidin from Staphylococcus aureus and toxin distribution among hospital strains.

V Finck-Barbançon1, G Prévost, Y Piémont.   

Abstract

For purification of F and S components of the Panton-Valentine leukocidin, an easy three-step method using fast protein liquid chromatography was developed to replace the time-consuming purification procedures previously published. This technique enabled the recovery of 13 and 17 mg of purified F and S, respectively, per litre of culture supernatant. Affinity-purified neutralizing polyclonal antibodies were obtained against each individual component. One hundred and thirty-nine Staphylococcus aureus strains isolated from various clinical samples of hospitalized patients were screened by immunoprecipitation for Panton-Valentine leukocidin (PVL) production. Only 8 strains produced PVL; all originated from injured superficial soft tissues. Contrary to widespread opinion, the 8 PVL-producing strains were never associated with severe infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2068381     DOI: 10.1016/0923-2508(91)90099-v

Source DB:  PubMed          Journal:  Res Microbiol        ISSN: 0923-2508            Impact factor:   3.992


  24 in total

1.  Crystallization and preliminary crystallographic studies of both components of the staphylococcal LukE-LukD leukotoxin.

Authors:  Romain Galy; Fabien Bergeret; Daniel Keller; Lionel Mourey; Gilles Prévost; Laurent Maveyraud
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-05-23

2.  Relative contribution of Panton-Valentine leukocidin to PMN plasma membrane permeability and lysis caused by USA300 and USA400 culture supernatants.

Authors:  Shawna F Graves; Scott D Kobayashi; Kevin R Braughton; Binh An Diep; Henry F Chambers; Michael Otto; Frank R Deleo
Journal:  Microbes Infect       Date:  2010-02-19       Impact factor: 2.700

3.  Analysis of the specificity of Panton-Valentine leucocidin and gamma-hemolysin F component binding.

Authors:  Florent Meyer; Raymonde Girardot; Yves Piémont; Gilles Prévost; Didier A Colin
Journal:  Infect Immun       Date:  2008-10-06       Impact factor: 3.441

Review 4.  The bicomponent pore-forming leucocidins of Staphylococcus aureus.

Authors:  Francis Alonzo; Victor J Torres
Journal:  Microbiol Mol Biol Rev       Date:  2014-06       Impact factor: 11.056

5.  Leucotoxic activities of Staphylococcus aureus strains isolated from cows, ewes, and goats with mastitis: importance of LukM/LukF'-PV leukotoxin.

Authors:  Pascal Rainard; Juan-Carlos Corrales; M Belén Barrio; Thierry Cochard; Bernard Poutrel
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

6.  Sequencing of leucocidin R from Staphylococcus aureus P83 suggests that staphylococcal leucocidins and gamma-hemolysin are members of a single, two-component family of toxins.

Authors:  G Supersac; G Prevost; Y Piemont
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

7.  Interaction of the two components of leukocidin from Staphylococcus aureus with human polymorphonuclear leukocyte membranes: sequential binding and subsequent activation.

Authors:  D A Colin; I Mazurier; S Sire; V Finck-Barbançon
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  GTP-binding proteins are involved in the modulated activity of human neutrophils treated with the Panton-Valentine leukocidin from Staphylococcus aureus.

Authors:  T Hensler; M Köller; G Prévost; Y Piémont; W König
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

9.  Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities.

Authors:  G Prévost; B Cribier; P Couppié; P Petiau; G Supersac; V Finck-Barbançon; H Monteil; Y Piemont
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

10.  Possibility of separating toxins from bacteria associated with sudden infant death syndrome using anion exchange chromatography.

Authors:  D B Drucker; H A Aluyi; J A Morris; D R Telford; B A Oppenheim; B A Crawley
Journal:  J Clin Pathol       Date:  1992-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.